Cambridgeshire, United Kingdom

Stuart Robert Abercrombie

USPTO Granted Patents = 4 


Average Co-Inventor Count = 14.3

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Stuart Robert Abercrombie

Introduction

Stuart Robert Abercrombie is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of medical technology, particularly in the development of ingestible devices for therapeutic applications. With a total of four patents to his name, Abercrombie's work is paving the way for advancements in gastrointestinal treatment.

Latest Patents

Among his latest patents is an ingestible device designed for the delivery of therapeutic agents to the gastrointestinal tract. This innovative device can directly target desired tissues within the GI tract, such as the submucosa, mucosa, and mucus layer. The technology ensures that therapeutic agents are delivered in a safe, effective, and reliable manner. Additionally, the patent includes pharmaceutical compositions intended for treating various diseases or conditions in subjects who require such interventions.

Career Highlights

Abercrombie has worked with prominent companies in the biotechnology sector, including Biora Therapeutics, Inc. and Progenity, Inc. His experience in these organizations has allowed him to refine his expertise in developing cutting-edge medical devices.

Collaborations

Throughout his career, Abercrombie has collaborated with notable professionals in the field, including Jeffrey A. Shimizu and Mitchell Lawrence Jones. These partnerships have contributed to the advancement of his innovative projects.

Conclusion

Stuart Robert Abercrombie's work in the field of ingestible medical devices showcases his commitment to improving healthcare through innovation. His patents reflect a dedication to enhancing therapeutic delivery methods, which could significantly impact patient care in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…